Aclaris Therapeutics Stock Overlap Studies Weighted Moving Average

ACRS Stock  USD 1.26  0.08  6.78%   
Aclaris Therapeutics overlap studies tool provides the execution environment for running the Weighted Moving Average study and other technical functions against Aclaris Therapeutics. Aclaris Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Weighted Moving Average study function is designed to identify and follow existing trends. Aclaris Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was two with a total number of output elements of fifty-nine. The Weighted Moving Average calculates a weight for each value in Aclaris Therapeutics price series with the more recent values given greater weights.

Aclaris Therapeutics Technical Analysis Modules

Most technical analysis of Aclaris Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aclaris from various momentum indicators to cycle indicators. When you analyze Aclaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aclaris Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aclaris Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aclaris Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Aclaris Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aclaris Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Aclaris Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Aclaris Therapeutics, we also check how macroeconomic factors affect Aclaris Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2023 2024 (projected)
Dividend Yield0.0037870.0043550.004138
Price To Sales Ratio122.02.3K2.5K
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aclaris Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.006.29
Details
Intrinsic
Valuation
LowRealHigh
0.000.006.29
Details
Naive
Forecast
LowNextHigh
0.021.147.43
Details
8 Analysts
Consensus
LowTargetHigh
27.3030.0033.30
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aclaris Therapeutics. Your research has to be compared to or analyzed against Aclaris Therapeutics' peers to derive any actionable benefits. When done correctly, Aclaris Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aclaris Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aclaris Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aclaris Therapeutics' short interest history, or implied volatility extrapolated from Aclaris Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Blockchain Idea
Blockchain
Invested a lot of shares
Business Services Idea
Business Services
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
When determining whether Aclaris Therapeutics is a strong investment it is important to analyze Aclaris Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclaris Therapeutics' future performance. For an informed investment choice regarding Aclaris Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Aclaris Stock analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Aclaris Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclaris Therapeutics. If investors know Aclaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclaris Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Revenue Per Share
0.448
Quarterly Revenue Growth
1.266
Return On Assets
(0.33)
Return On Equity
(0.50)
The market value of Aclaris Therapeutics is measured differently than its book value, which is the value of Aclaris that is recorded on the company's balance sheet. Investors also form their own opinion of Aclaris Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aclaris Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclaris Therapeutics' market value can be influenced by many factors that don't directly affect Aclaris Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclaris Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclaris Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclaris Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.